前收市價 | 0.6000 |
開市 | 0.6000 |
買盤 | 0.0000 |
賣出價 | 0.3000 |
拍板 | 22.50 |
到期日 | 2024-05-17 |
今日波幅 | 0.6000 - 0.6000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 11 |
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript May 8, 2024 Arcus Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.97. Arcus Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, all and welcome […]
Arcus Biosciences (RCUS) delivered earnings and revenue surprises of 94.85% and 454.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Adverum Biotechnologies (ADVM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.